Akebia Therapeutics to Present at Jefferies Global Healthcare Conference

CAMBRIDGE, Mass., May 23, 2024 /PRNewswire/ — Akebia Therapeutics®INC. (Nasdaq: AKBA), a biopharmaceutical company whose goal is to improve the lives of people affected by kidney disease, today announced that john butlerCEO, will present at the Jefferies Global Healthcare Conference on Wednesday June 5 in 9:00 a.m. Eastern Time.

The Jefferies Global Healthcare Conference will be held in New York, NY in June 4-6, 2024.

A webcast of the presentation can be accessed through the “Investors” section of Akebia’s website at for 30 days following the conference.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose of improving the lives of people affected by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at, which is not part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
(email protected)

SOURCE Akebia Therapeutics, Inc.

Related Articles

Back to top button